Suppliers / Jiangsu Synthgene Biotechnology

Jiangsu Synthgene Biotechnology

China Updated 9 July 2026

Jiangsu Synthgene Biotechnology is an API manufacturer based in China. It holds 7 active US drug master files across a filed portfolio of 7 molecules.

7
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Adenosine US FDA 1
Atp US FDA 1
Cytidine US FDA 1
Cytidine-5'-Triphosphate US FDA 1
Guanosine US FDA 1
Guanosine-5'-Triphosphate US FDA 1
Uridine 5'-Triphosphate US FDA 1

Also appears on these molecule pages

Adenosine API

Questions about Jiangsu Synthgene Biotechnology

Does Jiangsu Synthgene Biotechnology hold a US DMF or a CEP?
Jiangsu Synthgene Biotechnology holds 7 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Jiangsu Synthgene Biotechnology make?
7 molecules are on record against Jiangsu Synthgene Biotechnology, including Adenosine, Atp, Cytidine and Cytidine-5'-Triphosphate. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Synthgene Biotechnology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hisun Pharmaceutical shares 1 molecule Pharma Waldhof shares 1 molecule Guangxi Mingjian Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability